Sign in

CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Gain Therapeutics, Inc.

Sign in to watch
Ticker
GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851726310
Phone
(301) 500-1556
Business address
4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 8-K Event Regulation FD disclosure · Other events
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Regulation FD disclosure
  9. 8-K Event Delisting notice
  10. 4 Insider Changes in Ownership
  11. 8-K Event Executive or director change · Regulation FD disclosure
  12. 8-K Event Regulation FD disclosure · Other events
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Other events
  16. 8-K Event Regulation FD disclosure · Other events
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 424B5 Offering Prospectus
  19. 8-K Event Material agreement
  20. 4 Insider Changes in Ownership

Page 4 of 13 · 242 filings